7th International CAA Conference

30 SEPTEMBER | 1 OCTOBER

Welcome to the 7th International Cerebral Amyloid Angiopathy Conference. We have crafted a program that features cutting-edge research, translational ideas for clinical trials, and new knowledge on prevention and treatment of manifestations of CAA such as hemorrhagic stroke.

REGISTER
Eric Smith, MD, MPH
Steven Greenberg M.D. Ph.D.
Mark van Buchem MD, PhD
253
days
19
hours
54
min
45
sec

Message from the Chair

 

 

 

The 7th International CAA Conference has moved online and will be held on Wednesday September 30 and Thursday October 1, 2020.

 

Please note the change in the dates. We have shifted the conference 1 day forward, to better accommodate those who wish to attend live in the Australian time zones.

 

The conference will include live symposia, speaker questions and answers with moderated chat, a question and answer session on CAA for trainees, online posters that attendees can browse and chat with the presenters, and trainee awards.

 

The preliminary program is available at this site.

 

Please take note of these important dates:

 

July 24: Abstract submissions close. CLOSED

August 1: Registration opens

Sept 30 – Oct 1: Online conference

 

We look forward to seeing you online.

 

regards,

 

Eric Smith, MD, MPH

Professor of Neurology, University of Calgary

Chair, 7th International CAA Conference Organizing Committee

 

This meeting is endorsed by the European Stroke Organization. It is open to all who are interested in cerebrovascular diseases

www.eso-stroke.org

www.eso.kenes.com

European Stroke Organisation

 

 

Reservation Desk

Please register for the 7th International Cerebral Amyloid Angiopathy Conference, to be held online on September 30 and October 1. The theme of the conference is Converting Knowledge to Action: Designing Clinical Trials for CAA.

 

This conference will be of interest to basic scientists, clinical researchers, and clinicians. The online conference will feature 3 hours of programming each day for two days, additionally with online poster presentations with asynchronous chat with poster presenters. Fourteen lectures will cover topics including new therapeutic approaches to CAA, vascular and perivascular clearance mechanisms for beta-amyloid, pathophysiology of the neurovascular unit in CAA, neuroimaging biomarkers, clinical trial design, and the new diagnostic criteria, the Boston Criteria 2.0.

 

The reduced registration fees are 50 euros for regular registration, 25 euros for students and trainees. Student registration is open to anyone enrolled in a university graduate or undergraduate program, medical residency, or post-doctoral fellowship program (including MD post-doctoral fellows).

 

Register here

This meeting is endorsed by the European Stroke Organization. It is open to all who are interested in cerebrovascular diseases.

European Stroke Organisation

www.eso-stroke.org

www.eso.kenes.com

Program online conference

WEDNESDAY SEPTEMBER 30

Eastern Daylight Time

Central European Summer Time

Topic

Speaker

9:00

15:00

Opening Remarks

Eric Smith, University of Calgary

Symposium: Cerebral Amyloid Angiopathy as a Transmissable Proteinopathy

9:10

15:10

Keynote: Prion diseases 

John Collinge, University College London

9:30

15:30

Iatrogenic CAA: An Emerging Clinical Phenomenon

Gargi Banerjee, University College London

9:45

15:45

Oral Abstracts

 

Symposium: New Therapeutic Strategies for CAA

10:15

16:15

RNA Inhibition Therapies

Roger Lane, Ionis Pharmaceuticals

10:30

16:30

Minocycline as a Therapeutic Agent for CAA

Marieke Wermer, Leiden University Medical Center

10:45

16:45

Design considerations for CAA trials

Steven Greenberg, Mass General Hospital

11:00

17:00

Oral Abstracts

 

Trainee Session

11:40

17:40

Q&A on CAA

Steven Greenberg (Mass General Hospital), Charlotte Cordonnier (University of Lille), David Werring (University College London)

12:10

18:10

End

 
       

THURSDAY OCTOBER 1

Eastern Daylight Time

Central European Summer Time

Topic

Speaker

9:00

15:00

Welcome

Eric Smith, University of Calgary

Symposium: Biomarkers of CAA

9:05

15:05

Biofluid biomarkers of AD and CAA

Ralph Martins, Macquarie University

9:15

15:15

PET imaging of CAA

Christopher Rowe, University of Melbourne

9:25

15:25

Biomarker Evolution in Presymptomatic HCHWA-D Mutation Carriers

Jeroen van der Grond, Leiden University Medical Center

9:40

15:40

Oral Abstracts

 

 

 

 

 

       

Symposium: Neurovascular Unit Response to CAA

10:10

16:10

Microvascular architecture in relation to blood flow

Sylvie Lorthois, Institut de Mécanique des Fluides de Toulouse

10:25

16:25

Imaging the neurovascular unit response to microbleed

Andy Shih, University of Washington

10:40

16:40

High resolution MRI of microvessel structure/function

Jaco Zwanenburg, University Medical Center Utrecht

10:55

16:55

Oral Abstracts

 
       

Symposium: Beta-Amyloid Clearance via Perivascular and Other Drainage Routes

11:25

17:25

Cerebrospinal Fluid and Blood Flow Oscillations in Sleep

Laura Lewis, Boston University

11:40

17:40

Perivascular Spaces as a Pathway for Amyloid Clearance

Erik Bakker, VU University Medical Center Amsterdam

11:55

17:55

Microvascular dynamics and amyloid clearance

Susanne van Veluw, Mass General Hospital

12:10

18:10

Oral Abstracts

 

12:30

18:30

End

 

 

abstract submission

 

*****ABSTRACT SUBMISSION DESK CLOSED*****

 

Dear All,
 
We are pleased to announce that the virtual online International CAA conference of 30 September | October, 2020, is accepting abstracts for presentation. The deadline for submissions is July 24, 2020
 
Any basic or clinical science related to CAA is eligible for presentation at the meeting. This includes basic research on causes and mechanisms of CAA, the relationship between CAA and Alzheimer’s Disease, epidemiology, neuropathology, biomarkers, therapeutics, clinical trials, outcomes, and clinical care. 
 
Abstracts will be accepted for oral presentation at the virtual conference, or for presentation at an online e-poster.
 
We look forward to helping you disseminate your research on CAA.
 
Sincerely yours,
Eric Smith
Mark van Buchem 
Steve Greenberg
 

 

Submission Guidelines
–        All abstracts must be submitted via office@icaaconference.org ONLY. Abstracts sent by fax will not be accepted.

–        All abstracts should be written in English.
–      It is the responsibility of the presenting author and the submitter to review the submission status & information and correct them. Submitters are responsible for any typo error in the abstract.
–        The presenting author’s name should be underlined.
–        The abstract should be limited to;
o   400 words (text only), or
o   300 words and up to 2 images or tables
 
Important Dates
Call for Abstract                                June 18, 2020
Abstract Submission Due                 July 17, 2020
 


Scientific Program Committee

Contact

MESSAGE SENT!

Organizing Committee 2020

Sponsors